Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02713178 · ClinicalTrials.gov registry record · Phase 3
Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty
A Phase 3 study of Pain, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 232
- Enrollment target
- 17
- Study locations
NCT02713178: Completed Phase 3 study of Pain, sponsored by Pacira Pharmaceuticals.
NCT02713178 is a Phase 3 study of Pain that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 232 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (24% lower). The trial reports 17 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02713178, a Phase 3 study of Pain, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 232 participants
- Enrollment target
- 17
- Study locations
Study Summary
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study in 232 adult subjects undergoing primary unilateral TKA under general or spinal anesthesia.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG bupivacaine liposome injectable suspension
Study Locations (17)
Pennsylvania
- Indiana Regional Medical Center - Indiana
- Thomas Jefferson University Hospital - Philadelphia
- Chan Soon-Shiong Medical Center - Windber
Other
- Ziekenhuis Oost-Limburg - Genk
- Aarhus University Hospital - Aarhus C
- Regionshospital Silkeborg - Silkeborg
Florida
- Jackson Memorial Hospital/University of Miami - Miami
- Pensacola Research Associates - Pensacola
Massachusetts
- Brigham and Women's Hospital - Boston
- Massachusetts General Hospital - Boston
Texas
- Hermann Drive Surgical Hospital - Houston
- Westside Surgical Hospital - Houston
Alabama
- Horizon Research Group, Inc - Mobile
Colorado
- Denver Metro Orthopedics - Englewood
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2016-06-03 |
| Est. Completion | 2017-06-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02713178
The ClinicalTrials.gov registry entry for NCT02713178 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (24% lower). The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02713178 reports 17 study locations spanning 10 distinct geographic areas - top geographies include Pennsylvania, Other, Florida.
Frequently Asked Questions
What is clinical trial NCT02713178 about?
NCT02713178 is a clinical study titled "Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty". This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study in 232 adult subjects undergoing primary unilateral TKA under general or spinal anesthesia.
What is the current status of trial NCT02713178?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 232 participants. The study started on 2016-06-03. Estimated completion is 2017-06-30.
What conditions does trial NCT02713178 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT02713178?
The interventions under investigation include: Placebo (DRUG), bupivacaine liposome injectable suspension (DRUG).
Who is sponsoring clinical trial NCT02713178?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02713178 being conducted?
This trial has 17 study locations across Alabama, Colorado, Florida, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.